Zhengye Biotechnology Holding (ZYBT) Total Non-Current Liabilities (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Total Non-Current Liabilities data on file, last reported at $1.3 million in Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $1.3 million, up 95.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 95.82% YoY), and the FY2025 annual result was $1.3 million, up 101.82% from the prior year.
• Total Non-Current Liabilities rose to $1.3 million in Q4 2025 per ZYBT's latest filing, from $656000.0 in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $1.4 million in Q4 2023 and troughed at $656000.0 in Q2 2025.
• A 3-year average of $1.0 million and a median of $988393.9 in 2024 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities slumped 53.66% in 2024, then surged 95.82% in 2025.
• A 3-year view of Total Non-Current Liabilities shows it stood at $1.4 million in 2023, then tumbled by 53.66% to $668235.5 in 2024, then surged by 95.82% to $1.3 million in 2025.
• Business Quant data shows ZYBT's Total Non-Current Liabilities at $1.3 million in Q4 2025, $656000.0 in Q2 2025, and $668235.5 in Q4 2024.